![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 18, 15445-15451, May 3, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, December 14, 2001, and in revised form, February 13, 2002
p50, the major core protein bound to mammalian
mRNAs, has been reported to stimulate translation at low
p50/mRNA ratios and inhibit translation at high p50/mRNA
ratios. This study aims to address the molecular mechanisms underlying
these phenomena using the in vitro assembly of 48 S
preinitiation complexes from fully purified translational components in
the presence or absence of p50 as analyzed by the toeprint assay. With
limited concentrations of eIF2, eIF3, and eIF4F, p50 (but not
pyrimidine tract-binding protein, which was taken for
comparison) strongly stimulates formation of the 48 S preinitiation
complexes with mRNPs1 isolated from the
cytoplasm of different mammalian cells contain two major core proteins
that migrate in the SDS-PAGE electrophoresis as 70- and 50-kDa proteins
(1). The 70-kDa protein (poly(A)-binding protein) is bound to the
poly(A) tail of mRNA and is the most widely studied mRNP to
date, both structurally and functionally (2-5). The functional role of
p50, which is tightly bound to other parts of mRNA molecules,
is poorly understood.
According to its amino acid sequence and affinity for DNA, p50 was
identified as a member of the family of cold shock domain-containing proteins that is evolutionarily conserved from bacteria to man (6). Its
actual relative molecular mass was determined as 36 kDa (6). Some
proteins of this family are known as transcription factors affecting
expression of genes containing Y-box sequence elements in their
promoters (7-9). The bulk of mammalian p50, however, is localized in
the cytoplasm where it is tightly bound to mRNAs (10). Its
ubiquitous occurrence in mammalian cells (1), the fact that the protein
has a low specificity for RNA in in vitro binding
experiments (6-11), and the fact that its content in mammalian mRNAs
correlates with their translatability (12, 13) and stability
(13) suggests that p50 may fulfil the role of a general modulator of
mRNA translational activity.
In support of this hypothesis, it has been shown earlier that p50
strongly inhibits translation of exogenous mRNA in cell-free translation systems (12-15) as well as during translation in
vivo of mRNA expressed from a reporter gene (10). In
Xenopus oocytes, two proteins closely related to p50 were
reported to be responsible for the masked state of mRNA (15-19).
Therefore, it is conceivable that mammalian p50 plays a similar role
thereby determining the level of translational repression of mRNAs.
However, we have demonstrated that p50 not only inhibits but also
stimulates translation depending on the p50/mRNA ratio in a
cell-free system (12, 20). These experiments were performed with the
use of a rabbit reticulocyte lysate depleted of p50 with specific
antibodies. The p50-depleted lysate showed a low translational
activity, whereas addition of p50 partially restored the level of
polypeptide synthesis. We have also shown that p50 exerts its effect at
the level of translation initiation rather than at the level of
elongation or termination of polypeptide synthesis (20). To understand
the mechanisms at play, additional experimentation in a more
defined system is required. In addition, the depleted lysate system did
not allow us to judge which step of translation initiation was
stimulated or inhibited by the protein.
In this report, we present experiments designed to address the
molecular mechanisms of the action of p50 on translation initiation using the in vitro assembly of 48 S preinitiation complexes
from purified translational components in the presence of different amounts of p50. The yield of reconstituted complexes was monitored by
the toeprint assay (21). It was found that p50 affects translation initiation at the level of 48 S preinitiation complex formation. At a
low p50/mRNA ratio, the protein stimulates binding of 40 S
ribosomal subunits to the initiation triplet of Preparation of RNA--
Native globin mRNAs were isolated
from rabbit reticulocyte polysomes washed with 0.5 M KCl.
Total RNA was phenol-extracted from 1000 A260
units of the salt-washed ribosomes, and poly(A+) RNA was
isolated with the use of a poly(A+) RNA isolation kit
(Amersham Biosciences). The mRNA was then layered on a 5-20%
sucrose gradient in 20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 0.1% SDS and centrifuged at 4 °C in a SW41
rotor (Beckman) for 15 h at 35,000 rpm. The material from the 9 S
region of the gradient was pooled, and the globin mRNA was
precipitated with ethanol. Polyacrylamide gel electrophoresis showed no
contamination of the globin mRNA with ribosomal RNA. The isolated
material represented a mixture of Preparation of Factors, 40 S Ribosomal Subunits, mRNA-binding
Proteins, and [35S]Methionine-labeled
Met-tRNA Assembly and Analysis of 48 S Preinitiation Ribosomal
Complexes--
Ribosomal 48 S preinitiation complexes were assembled
as described earlier (21, 22), but the amounts of initiation factors eIF2, eIF3, and eIF4F were decreased. In this study, 0.2 µg (~1 pmol) of native globin mRNA was incubated with eIF1 (0.5 µg), eIF1A (0.5 µg), eIF2 (0.9 µg), eIF3 (1.2 µg), eIF4F (0.2 µg), eIF4A (0.5 µg), eIF4B (0.3 µg),
Met-tRNA Chemical Footprinting--
The sugar-phosphate backbone of the
RNA in the p50· Quantitative Western Blotting of p50 Bound to
mRNA--
p50 Affects the Binding of 40 S Ribosomal Subunits to the
Initiation Codon in the in Vitro Assembly of 48 S Preinitiation
Complexes from Purified Components--
For the reconstitution assay
we used a set of purified canonical initiation factors (eIF1, eIF1A,
eIF2, eIF3, eIF4F, eIF4A, and eIF4B), reticulocyte 40 S ribosomal
subunits, total calf liver tRNA where only the initiator tRNA was
charged with methionine, native globin mRNA, and p50 (added to this
system in varying amounts). After a short incubation, a primer and
reverse transcriptase were added to the mixture, and the length of
cDNAs resulting from primer extension were determined. The
influence of p50 on assembly of the 48 S preinitiation complex was
quantitatively estimated by the intensity of toeprint bands at
positions +16 to +18 downstream from the AUG initiation triplet. It has
been well established that the arrest of reverse transcriptase occurs
at positions +16 to +18 (toeprint bands) only when the initiator tRNA
forms a codon-anticodon interaction with the mRNA initiation
triplet in the P-site of the 40 S ribosomal subunit or 80 S ribosome
(21, 28, 29). No arrest of primer extension at these positions occurs
when the initiator tRNA is absent from the 40 S ribosomal subunit or 80 S ribosome.
No effect of p50 was found using published protocols (21, 22) for
assembly of 48 S preinitiation complexes (data not shown). However,
when the concentration of eIF2, eIF3, and eIF4F was reduced about
3-fold resulting in 7, 2, and 0.8 pmol/1 pmol of mRNA, up to a
4-fold stimulation by p50 was observed on the yield of 48 S
preinitiation complexes (Fig. 1). (It
should be noted that the yield of 48 S complexes was quantitated as the
percentage of toeprint radioactivity to the total radioactivity in the
same lane. In this way, any variation caused by positive or negative
effects of p50 on the transcription reaction itself were excluded.)
Similar toeprint results were obtained when using the primer
5'-CACATTCATTCACCTTCG-3' (data not shown). Its annealing site is
separated from the toeprint nucleotides by just 32 nucleotide
residues.
Stimulation was observed before the p50/mRNA ratio exceeded 30 (Fig. 1, lane 6). When the amount of p50 was further
increased 2-fold, a repression of 48 S complex formation was evident
(Fig. 1, lane 7). This inhibitory effect could be relieved
by adding more of initiation factors eIF4F and eIF2 (Fig.
2, lanes 4, 5, and
8). The strongest effect was demonstrated for initiation
factor eIF2 (Fig. 2, lane 8), whereas excess eIF3 was
slightly inhibitory (Fig. 2, lanes 6 and 7). A
further increase of the p50/mRNA ratio to 100 resulted in even
greater suppression of 48 S complex formation, and addition of the
same amounts of initiation factors (eIF2 or eIF4F) as indicated for
Fig. 2 did not relieve this inhibition (data not shown).
p50 Is Able to Stimulate the Formation of Nonpositioned 48 S
Complexes Bound near the 5'-End of mRNA--
As has been shown by
Pestova et al. (22), omission of initiation factors eIF1 and
eIF1A from the reconstitution mixture results in formation of an
aberrant 5'-terminal initiation complex. To be formed, this aberrant
complex still requires all of the other translation initiation
components including Met-tRNA Ability of p50 to Promote Formation of 48 S Preinitiation Complexes
from Purified Components at Low p50/mRNA Ratios Is Not a Common
Property of mRNA-binding Proteins--
One may suspect that any
mRNA-binding protein with highly basic domains would promote
assembly of the 48 S complex in the manner demonstrated above for p50.
If so, the stimulation effect would be regarded as nonspecific. In this
regard, one may recall an example of this kind: general RNA-binding
proteins, as different as hnRNPA1, La autoantigen, PTB, and p50, all
render translation in a rabbit reticulocyte lysate more
cap-dependent irrespective of their cellular function and
individual characteristics (30). To check this possibility, effects of
the highly basic mRNA-binding protein PTB and p50 were compared in
parallel assays of the 48 S preinitiation complex formation. As can be
seen in Fig. 4, PTB does not stimulate
the formation of the 48 S complex with
At higher concentrations, PTB strongly inhibited not only formation of
the 48 S complex but also the reverse transcription reaction as seen by
the decrease of full-length product of primer extension (Fig. 4,
lanes 6-9, upper bands). Presumably PTB
interferes with either annealing of a primer to the mRNA chain or
elongation of the cDNA product or both by virtue of its interaction
with nucleotide bases (pyrimidines). In contrast, p50 does not inhibit the reverse transcription reaction (the yield of the full-length product) even at the p50/mRNA ratio of about 100 or more (when formation of 48 S complexes is strongly repressed; Fig. 2 and data not
shown). Nucleotide bases appear to remain exposed in solution and
available for interaction with RNA or protein components of
translational machinery.
p50 Binds to the Sugar-Phosphate Backbone of mRNA and Reveals a
Preference for Sequences with Completely Unpaired Nucleotide
Bases--
As follows from the results presented above, p50 does not
inhibit reverse transcription even at high p50/mRNA ratios. These observations and the data reported earlier (6) suggest that p50 does
not recognize nucleotide bases of mRNA. Chemical probing of
p50·
At a p50/mRNA ratio of about 30, the sites of protection by p50 of
the sugar-phosphate backbone are distributed along the whole length of
Binding of Just a Few Molecules of p50 Per Molecule of
Aliquots from different fractions of the mRNP peak were then analyzed
by SDS-PAGE along with a series of known amounts of p50. After transfer
of the proteins onto a nitrocellulose membrane, the corresponding bands
were developed with an ECL Western blotting system and quantified by
densitometric scanning. The immunological response to increasing
amounts of p50 was linear in the selected range of p50 used (Fig.
7B). In Fig. 7C, the same Western blotting experiment demonstrates a response of p50 antibodies to aliquots from
the three different fractions of the p50/mRNA peak.
In a series of independent experiments, the p50/mRNA ratio in the
mRNP peak varied from 6 to 8. This value represents the average number
of p50 molecules bound to the We have recently shown that p50 plays not only a negative but also
a positive role in translation and that this positive effect is exerted
at the level of translational initiation (19). Here, using the
reconstitution of the initiation complexes with purified components, we
present strong evidence that p50 stimulates the binding of the 40 S
ribosomal subunit at the initiation codon of mRNA. The stimulation
reaches its maximum when less than 10 molecules of p50 are bound per
one mRNA molecule of the size of rabbit With this low occupancy of mRNA, it is not immediately evident how
this RNA-binding protein may affect the events that occur at the 5'-end
of mRNA. There are two features, however, that distinguish p50 from
the overwhelming majority of mRNA-binding proteins studied to date
(33) and that may be a key to answer the question. As was reported
previously (6) and confirmed here, the binding of p50 to mRNA does
not engage the nucleotide bases. It binds the sugar-phosphate backbone
and has no preferred sequence motifs on mRNAs. However, it has a
great preference for the sequences with unpaired and probably weakly
stacked nucleotide bases. We speculate that these properties primarily
target p50 to the most unstructured regions within the mRNA
molecules that are presumably also preferred sites for aberrant binding
of initiation factors or other mRNA-binding proteins. As
nonspecific RNA-protein interactions take place at the sugar-phosphate
backbone of RNA, p50 efficiently displaces them from the irrelevant
sites without interfering with specific interactions that normally
involve nucleotide bases. In this way, one may easily imagine why just
a few molecules of p50 are able to stimulate translation initiation,
the process that is confined to a rather limited region of mRNA
nucleotide sequence. The corresponding model that extends the model
suggested earlier by Minich and Ovchinnikov (12) is presented in Fig. 8. The competition between key initiation
factors eIF4F and eIF2 and p50 was clearly demonstrated in this study.
The inability of p50 to stimulate the assembly of the 48 S complex at
high molar excesses of eIF2 and eIF4F is also in line with this
interpretation. The model ("competitive model") describes p50 as a
general organizer of RNA-protein interactions in mRNPs.
In contrast, another mRNA-binding protein, PTB, fails to promote
the binding of 40 S subunits to the start codon of One should bear in mind that p50 possesses prominent RNA unwinding
properties (6, 23). This feature presumably also based on its strong
affinity to single-stranded sequences may allow p50 to modulate
mRNA secondary structure (see Ref. 36), thereby facilitating
interaction of initiation factors and 40 S ribosomal subunit with the
RNA polynucleotide chain. None of the experiments described above
excludes this possibility. However, the bulk of evidence presented in
this paper offers support for the competitive model.
It should be pointed out that the stimulatory effect of p50 on
translation initiation at low p50/mRNA ratios and its repressive effect at high p50/mRNA ratios may be based on somewhat different features of p50. Whereas the stimulation is observed under conditions of a large separation between individual molecules of p50 on the polynucleotide chain, its repressive effect becomes prominent when p50
molecules seem to establish protein-protein contacts. This is the most
plausible explanation for a remarkable inhibition of the toeprint even
at a low p50/mRNA ratio for the (CAA)n- We thank Dmitri Kolkevich and Yakov Alexeev
for technical assistance. We gratefully acknowledge John Hershey for
providing us with eIF1A cDNA. We thank Richard Jackson, Yuri
Svitkin, and Alan Sachs for interesting discussion of the
data presented in this report.
*
This work was supported by grants from INTAS (to
A. A. T., L. P. O., and I. N. S.), from the Russian
Foundation for Basic Research (to I. N. S. and L. P. O.), and the
United States Civilian Research and Development Foundation (to
W. C. M. and I. N. S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed. Tel.:
7-095-939-4857; E-mail: Shatsky@libro.genebee.msu.su.
Published, JBC Papers in Press, February 19, 2002, DOI 10.1074/jbc.M111954200
2
T. Pestova, personal communication.
The abbreviations used are:
mRNP, messenger
ribonucleoprotein;
PTB, pyrimidine tract-binding protein;
eIF, eukaryotic initiation factor;
nt, nucleotide(s).
Positive and Negative Effects of the Major Mammalian Messenger
Ribonucleoprotein p50 on Binding of 40 S Ribosomal Subunits to the
Initiation Codon of
-Globin mRNA*
,
,
**
A. N. Belozersky Institute of
Physico-Chemical Biology, Moscow State University, 119899 Moscow,
Russia, the § Institute of Protein Research, Russian
Academy of Sciences, 142292 Pushchino, Moscow Region, Russia, the
¶ Department of Development Biology, Utrecht University, 3584 CH
Utrecht, the Netherlands, and the
Department of
Biochemistry, Case Western Reserve University, School of Medicine,
Cleveland, Ohio 44106
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-globin mRNA. This stimulation is observed when
just a few molecules of p50 are bound per molecule of the mRNA.
When the amount of p50 in solution is increased over some threshold
p50/mRNA ratio, a remarkable repression is observed that can still
be relieved by adding more eIF2 and eIF4F. At even higher
concentrations of p50, the inhibitory effect becomes irreversible. The
threshold ratio depends upon the extent of secondary structure of the
5'-untranslated region linked to the
-globin coding region. Chemical
probing has confirmed that the binding of p50 to mRNA involves only
the sugar-phosphate backbone of the mRNA leaving nucleotide bases
free for interaction with other messenger ribonucleoprotein (mRNP)
components. These data are best compatible with the functional role of
p50 as a "manager" of mRNA-protein interactions in mammalian mRNPs.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-globin mRNA. This stimulation was specific for p50 rather than a common feature of
cytoplasmic mRNA-binding proteins. At p50 concentrations exceeding some threshold p50/mRNA ratio, a remarkable repression is observed, the threshold ratio being dependent on the secondary structure of the
5'-untranslated region linked to the
-globin coding region.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
- and
-globin mRNAs. These
RNAs behave similarly in reconstitution of 48 S preinitiation complexes
and have a similar size (22). In this study, the 48 S preinitiation
complex was analyzed only for formation of the 48 S preinitiation
complex with
-globin mRNA. [32P]
-Globin
mRNA was synthesized in vitro by a T3 transcription reaction using the plasmid p
-Glo linearized with SacI.
p
-Glo represented a
-globin cDNA inserted between the
HindIII and SacI sites of the plasmid pBS
(Stratagene). (CAA)n-
-globin mRNA was obtained by T7
transcription of plasmid p(CAA)n-
Glo linearized with
SacI. The plasmid was constructed by replacement of the
-glucuronidase (GUS) coding region in the p(CAA)n-GUS
vector at the NcoI site with the
-globin coding region
produced using PCR. p(CAA)n-GUS vector was a gift of Dr.
I.V. Boni (Moscow, Russia).

-D-galactopyranoside and
after 5 h at 23 °C were sonicated and clarified with a low speed centrifugation, and a 40-70% ammonium sulfate fraction was prepared from the supernatant. The dialyzed proteins were applied to a
DEAE-cellulose column equilibrated with buffer containing 20 mM Tris-HCl, pH 7.5, 100 mM KCl, 0.1 mM EDTA, 1 mM dithiothreitol, and 10% glycerol
(buffer A100). The flow-through was applied to a Mono S HR 5/5 column
(Amersham Biosciences), and eIF1 resolved at this step was concentrated
and dialyzed against buffer A100. The eIF1A expression plasmid and
factor eIF1A were prepared exactly as described by Pestova et
al. (22), starting from the eIF1A cDNA-containing plasmid
kindly provided by Dr. John Hershey. Purification of PTB and p50 was as
described previously (20, 26). Both mRNA-binding proteins were
purified to homogeneity using RNA affinity columns as the last step of
purification. [35S]Methionine-labeled
Met-tRNA

-globin mRNA sequence, respectively. Electrophoresis of
cDNAs was performed by denaturing 6% PAGE. Radioactive bands were
visualized, and relative amounts of radioactivity in the bands were
determined using a PhosphorImager (Molecular Dynamics).
-globin mRNA binary complexes was probed
with Fe(II)·EDTA according to the protocol described for the
modification of ribosomal complexes (27). These complexes were formed
in the buffer used for reconstitution of the 48 S preinitiation complexes.
-Globin mRNA was synthesized in vitro
with T3 polymerase in the presence of [
-32P]UTP as
described previously (21). The RNA was freed of unincorporated [
-32P]UTP by gel filtration, and its specific
radioactivity was determined by A260 and
Cerenkov counting. Finally the integrity of the RNA was confirmed by
denaturing 6% PAGE. The 32P-labeled
-globin mRNA (5 pmol) was incubated with the corresponding amounts of all other
translation initiation components under conditions of the 48 S complex
formation (see above) with addition of 150 pmol of p50 (p50/mRNA
ratio = 30). The mixture was incubated for 5 min at 30 °C and
layered on a 5-20% sucrose gradient prepared in the reconstitution
buffer. After centrifugation at 4 °C for 19 h at 33,000 rpm,
the mRNP peak was isolated. The RNA content of the mRNP peak was
determined by Cerenkov counting, and 60-µl aliquots along with
different amounts of p50 were subjected to 10% PAGE. Proteins were
transferred to nitrocellulose membranes under semidry conditions
(Semi-Phor, Hoefer Scientific Instruments), and then membranes were
processed as described earlier (21) using polyclonal rabbit p50
antiserum diluted 5000-fold (20). Bands were revealed using an ECL
system. After scanning the bands, the amount of p50 in the aliquots of
the mRNA peak was determined using the calibration plot obtained from
control bands of p50 (run on the same gel, see above).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (32K):
[in a new window]
Fig. 1.
Effect of p50 on the reconstitution of the 48 S translation preinitiation complex with
-globin mRNA. Primer extension inhibition
(toeprinting) was performed in the presence or absence of p50. The
p50/mRNA ratios indicated are molar ratios. "c"
denotes a control sample where eIF2 was omitted to demonstrate the
specificity of toeprint formation. A dideoxynucleotide sequence
generated with the same primer (5'-TCACCACCAACTTCTTCCAC-3') was run in
parallel. The positions of the initiation AUG codon and toeprint are
shown in bold on the right of the sequence. The
yield of 48 S complexes was quantitated with a PhosphorImager as the
ratio of radioactivity in toeprint bands relative to the total
radioactivity of the respective lane.

View larger version (28K):
[in a new window]
Fig. 2.
eIF2 and eIF4F relieve the inhibition of the
48 S complex formation at higher p50/mRNA ratios. The
formation of 48 S complexes was analyzed as indicated in the legend to
Fig. 1, but dideoxynucleotide sequencing was omitted. Lanes
1-3 contain standard amounts of the factors as indicated under
"Experimental Procedures." The amount of eIF2, eIF3, and eIF4F
added in lanes 4-8 was 2- or 3-fold more than indicated
under "Experimental Procedures."

-globin mRNA during the scanning
process. As seen from Fig. 3 (lanes
1 and 2), omission of eIF1 and eIF1A resulted in
appearance of the aberrant 5'-terminal initiation complex with
concomitant disappearance of the authentic 48 S initiation complex.
Addition of increasing amounts of p50 to this reconstitution mixture
demonstrates stimulation of the 5'-terminal complex formation up to the
same threshold p50/mRNA ratio = 30 as was found before for the
authentic 48 S complex (Fig. 3, lanes 3-5). Thus, the
stimulation effect is not based, at least entirely, on involvement of
the protein in the scanning process of the 5'-leader of
-globin
mRNA.

View larger version (19K):
[in a new window]
Fig. 3.
Effect of p50 on the reconstitution of the
aberrant 5'-terminal 40 S·
-globin mRNA
complex formed in the absence of initiation factors eIF1 and
eIF1A. The formation of 40 S ribosome·mRNA complexes was
analyzed as indicated in the legend to Fig. 1.
-globin mRNA; in fact,
its addition is inhibitory. This is in agreement with our previous
report that PTB did not stimulate translation of
-globin mRNA in
PTB-depleted cell extracts (31).

View larger version (16K):
[in a new window]
Fig. 4.
Comparative study of effects of p50 and PTB
on the formation of 48 S preinitiation complexes with
-globin mRNA at different protein/mRNA
ratios. The amounts of p50 indicated under lanes 2-5
correspond to p50/mRNA molar ratios of 10, 20, 30, and 60, respectively. "c" (lane 10) denotes a control
where eIF2 was omitted from the incubation mixture.
-globin mRNA complexes confirmed this suggestion. No
protection of nucleotide bases was found when p50·mRNA binary
complexes were treated with dimethylsulfate (A and C residues) or
1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide metho-p-toluenesulfonate (U residues). At low p50/mRNA
ratios, protection of the sugar-phosphate backbone of mRNA from
modification with Fe(II)·EDTA complexes was not seen either (data not shown).
-globin mRNA with a preference for some sequences of the
mRNA (Fig. 5, lanes 1 and
4). This preference may be accounted for by different
potential for base pairing of different nucleotide sequences. In its
turn, this may result in differential p50 binding to different parts of
the mRNA. Indeed p50 is known to have a much higher affinity for
single-stranded than double-stranded nucleic acids. Fig.
6 presents an obvious illustration of
this feature. Here the effect of p50 on the 48 S complex assembly is shown for the (CAA)n-
-globin mRNA. This mRNA
differs from native
-globin mRNA in its 5'-untranslated region,
CAAGAA(CAA)19CACCAUGG. . . . . , which makes up only
~
-globin hybrid mRNA, a remarkable inhibition of the toeprint is observed at the p50/mRNA ratio as low as 10 (Fig. 6, lane 2) that is 6-fold lower than the ratio with a
similar inhibitory effect for
-globin mRNA (compare with Figs. 1
and 2). For the natural
-globin mRNA, a ratio of
p50/mRNA of 10 demonstrates a stimulatory rather than an inhibitory
effect. These data present compelling evidence that p50 greatly prefers
long stretches of unpaired nucleotides. The p50 molecules bound
to the (CAA)n-mRNA are concentrated mostly within its
long unstructured 5'-leader and, as such, form a local inhibitory
complex. In this connection, it is not surprising that no stimulation
by p50 of the 48 S complex formation with the (CAA)n-leader
is seen at p50/mRNA ratios lower than 10. Apparently any
stimulation in this case should be negated by the concomitant
inhibitory binding of p50 within the (CAA)n-leader.

View larger version (20K):
[in a new window]
Fig. 5.
Interaction of p50 with the sugar-phosphate
backbone of
-globin mRNA as revealed by
Fe(II)·EDTA modification. Binding characteristics of p50 are
presented for the 5'-terminal part of
-globin mRNA (positions of
nucleotides from the 5' terminus of
-globin mRNA are shown to
the left of the panel). Similar results were obtained for
the next 100 nt of
-globin mRNA sequence (data not shown).
Vertical bars to the right of lane 4 show the mRNA sequences protected by p50 from chemical
modification. Lane 3 demonstrates the protection pattern for
initiation factor eIF4A used as a control protein for unspecific uptake
of the modifying reagent.

View larger version (21K):
[in a new window]
Fig. 6.
Effect of p50 on the assembly of the 48 S
preinitiation complex with
(CAA)n-
-globin mRNA. The
formation of the complex was analyzed as indicated in Fig. 1. A
dideoxynucleotide sequence generated with the same primer
(5'-CACCACCAACTTCTTCCAC-3') is shown at the left.
-Globin
mRNA Is Sufficient to Stimulate the 48 S Preinitiation Complex
Formation--
To get an idea about the mechanism of action of p50 on
the 48 S complex formation, it is useful to know how many molecules of
the protein need to be bound to the mRNA to observe an effect. As
follows from Figs. 1, 2, and 4, the stimulation is detected even at low
p50/mRNA ratios and increases up to some threshold value of about
30 p50 per mRNA after which the yield of the 48 S complexes rapidly
decreases. This does not mean, however, that these 30 molecules of p50
are all bound to the mRNA. The experimental conditions for the 48 S
complex assembly involve the addition of a large excess of uncharged
tRNA that is not participating in the reconstitution process. Although
the tRNA has a very low affinity for p50, its high concentration
sequesters some p50. This is evident from the sucrose gradient
sedimentation of p50·
-globin mRNA complexes in the presence or
absence of tRNA. In the latter case, a much heavier mRNP was formed
that rapidly sedimented to the bottom of the tube (Fig.
7A). Therefore, the number p50
molecules bound to the
-globin mRNA in the presence of a large
excess of tRNA was estimated. For this, 32P-labeled
mRNA with a known specific activity was incubated in the
reconstitution buffer with p50 in the presence of all the translation
initiation components needed to form the 48 S preinitiation complex.
The mRNA·p50 complex was separated from unbound p50 and tRNA by
sucrose gradient centrifugation, and the amount of mRNA in the mRNP
peak was determined by Cerenkov counting. Western blot experiments
performed in our laboratory showed that p50 does not dissociate from
the mRNA during sucrose gradient centrifugation presumably because
of its high affinity for single-stranded polynucleotides (data not
shown). This allowed us to use sucrose gradient centrifugation as a
technique to separate two pools of p50, the pool bound to mRNA and
that sequestered by tRNA.

View larger version (13K):
[in a new window]
Fig. 7.
Quantitative Western blotting of p50 in the
complex p50·
-globin mRNA. The
complex was formed at the p50/
-globin mRNA ratio of about 30 in
the presence of all translational components needed for reconstitution
of the 48 S complex and separated from unbound p50 by sucrose
gradient centrifugation. A shows a sucrose gradient
centrifugation of the p50·
-globin mRNA complex in the pres ence of a large excess of tRNA (filled squares) and in
its absence (open circles). Arrows indicate
fractions used to determine the p50/mRNA ratio in the mRNP peak.
Sedimentation of free
-globin mRNA is shown with filled
triangles. B demonstrates a dose response of different
amounts of p50 to anti-p50 and the corresponding calibration plot.
C demonstrates a response to anti-p50 of 60-µl aliquots
from three different fractions of the mRNP peak shown in Fig.
5A. Each 60-µl aliquot from fractions 19-21 contained
about 20 ng (~0.1 pmol) of
-globin mRNA. For other details see
"Experimental Procedures." AU, arbitrary
units.
-globin mRNA at the threshold p50
concentration when stimulation of the translation initiation gives way
to its inhibition.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-globin mRNA (the
length of the mRNA is 589 nt excluding the poly(A) tail that is
normally bound to poly(A)-binding protein). On average, this
results in a large separation between individual p50 molecules along
the polynucleotide chain. It should be stressed that the stimulation
can be observed at much lower p50/mRNA ratios (Fig. 1) and, hence,
occurs with an average distance of more than 100 nt between bound p50 molecules.

View larger version (14K):
[in a new window]
Fig. 8.
Model of the stimulation effect of p50 on the
48 S complex formation. The model shows how p50 may displace
eIF4F, and presumably other basic factors as well, from irrelevant
sites on the mRNA, thereby allowing them to be free for initiation
events at the 5'-end of the mRNA. For other explanations see the
text. 4E, eIF4E; 4A, eIF4A.
-globin mRNA.
Unlike p50, PTB may be "retained" by pyrimidine-rich sequences of
mRNA. It is logical, therefore, that PTB promotes translation initiation only in specific cases (some picornaviruses (34)), and its
stimulation effect appears to be of a quite different nature (35).
-globin mRNA. In this case, several molecules of p50 appear to
cooperatively bind within the 68-nt single-stranded leader of this
artificial mRNA leaving the remaining part of the 5'-untranslated
region essentially free of bound protein. This presumably results in transition of mRNP into a locked form (for model, see Ref. 37). In
contrast, a natural RNA requires a more complete filling of the
polynucleotide chain with p50 molecules to establish cooperative protein-protein interactions. At low p50/mRNA ratios, individual molecules of p50 are still separated by unoccupied structured RNA
elements that prevent them from establishing protein-protein contacts.
When these protein-protein interactions are finally achieved at the 5'
terminus of the mRNA, they start to compete with initiation factors
for binding with the 5'-untranslated leader. In particular, they should
interfere with interaction of mRNA-binding domain of eIF4G with the
5'-untranslated region. As a result (see Ref. 38), the overall affinity
of eIF4F to the mRNA will drop with a concomitant easier
dissociation of eIF4E from the cap structure. This model offers an
alternative explanation of some results recently reported by Evdokimova
et al. (13). An intriguing possibility is that some or all
types of mammalian cells are able to regulate the general level of
protein synthesis just by changing the intracellular concentration of
p50. As suggested by the experiment presented in Fig. 6, this may
differentially affect expression of mRNAs with unstructured and
highly organized 5'-untranslated regions. Studies on the regulation of
the synthesis of p50 itself that should clarify this interesting issue
are now in progress.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Jain, S. K.,
Pluskal, M. G.,
and Sarkar, S.
(1979)
FEBS Lett.
97,
84-90[CrossRef][Medline]
[Order article via Infotrieve] 2.
Gallie, D. R.
(1991)
Genes Dev.
5,
2108-2116 3.
Tarun, S. Z.,
and Sachs, A. B.
(1995)
Genes Dev.
9,
2997-3007 4.
Sachs, A. B.,
Sarnow, P.,
and Hentze, M. W.
(1997)
Cell
89,
831-838[CrossRef][Medline]
[Order article via Infotrieve] 5.
Deo, R. C.,
Bonanno, J. B.,
Sonenberg, N.,
and Burley, S. K.
(1999)
Cell
98,
835-845[CrossRef][Medline]
[Order article via Infotrieve] 6.
Evdokimova, V. M.,
Sitikov, A. S.,
Simonenko, P. N.,
Lazarev, O. A.,
Vasilenko, K. S.,
Ustinov, V. A.,
Wei, C.-L.,
Hershey, J. W. B.,
and Ovchinnikov, L. P.
(1995)
J. Biol. Chem.
270,
3186-3192 7.
Wolffe, A. P.,
Tafuri, S. R.,
Ranjan, M.,
and Famolari, M.
(1992)
New Biol.
4,
290-298[Medline]
[Order article via Infotrieve] 8.
Wolffe, A. P.
(1994)
Bioassays
16,
245-251[CrossRef][Medline]
[Order article via Infotrieve] 9.
Ladomery, M.,
and Sommerville, J.
(1995)
Bioassays
17,
9-11[CrossRef][Medline]
[Order article via Infotrieve] 10.
Davydova, E. K.,
Evdokimova, V. M.,
Ovchinnikov, L. P.,
and Hershey, J. W. B.
(1997)
Nucleic Acids Res.
25,
2911-2916 11.
Minich, W. B.,
Maidebura, I. P.,
and Ovchinnikov, L. P.
(1993)
Eur. J. Biochem.
212,
633-638[Medline]
[Order article via Infotrieve] 12.
Minich, W. B.,
and Ovchinnikov, L. P.
(1992)
Biochimie (Paris)
74,
477-483 13.
Evdokimova, V.,
Ruzanov, P.,
Imataka, H.,
Raught, B.,
Svitkin, Y.,
Ovchinnikov, L. P.,
and Sonenberg, N.
(2001)
EMBO J.
20,
5491-5502[CrossRef][Medline]
[Order article via Infotrieve] 14.
Minich, W. B.,
Volyanik, E. V.,
Korneeva, N. L.,
Berezin, Y. V.,
and Ovchinnikov, L. P.
(1990)
Mol. Biol. Rep.
14,
65-67[CrossRef][Medline]
[Order article via Infotrieve] 15.
Richter, J. D.,
and Smith, L. D.
(1984)
Nature
309,
378-380[CrossRef][Medline]
[Order article via Infotrieve] 16.
Marello, K.,
LaRovere, J.,
and Sommerville, J.
(1992)
Nucleic Acids Res.
20,
5593-5600 17.
Ranjan, M.,
Tafuri, S. R.,
and Wolffe, A. P.
(1993)
Genes Dev.
7,
1725-1736 18.
Bouvet, P.,
and Wolffe, A. P.
(1994)
Cell
77,
931-941[CrossRef][Medline]
[Order article via Infotrieve] 19.
Braddock, M.,
Muckenthaler, M.,
White, M. R. H.,
Thorburn, A. M.,
Sommerville, J.,
Kingsman, A. J.,
and Kingsman, S. M.
(1994)
Nucleic Acids Res.
22,
5255-5264 20.
Evdokimova, V. M.,
Kovrigina, E. A.,
Nashchekin, D. V.,
Davydova, E. K.,
Hershey, J. W. B.,
and Ovchinnikov, L. P.
(1998)
J. Biol. Chem.
273,
3574-3581 21.
Pestova, T. V.,
Hellen, C. U. T.,
and Shatsky, I. N.
(1996)
Mol. Cell. Biol.
16,
6859-6869[Abstract] 22.
Pestova, T. V.,
Borukhov, S. I.,
and Hellen, C. U. T.
(1998)
Nature
394,
854-859[CrossRef][Medline]
[Order article via Infotrieve] 23.
Skabkin, M. A.,
Evdokimova, V.,
Thomas, A. A.,
and Ovchinnikov, L. P.
(2001)
J. Biol. Chem.
276,
44841-44847 24.
Pestova, T. V.,
Shatsky, I. N.,
Fletcher, S. P.,
Jackson, R. J.,
and Hellen, C. U. T.
(1998)
Genes Dev.
12,
67-83 25.
Kasperaitis, M. A. M.,
Voorma, H. O.,
and Thomas, A. A. M.
(1995)
FEBS Lett.
365,
47-50[CrossRef][Medline]
[Order article via Infotrieve] 26.
Hellen, C. U. T.,
Pestova, T. V.,
Litterst, M.,
and Wimmer, E.
(1994)
J. Virol.
68,
941-950 27.
Huttenhofer, A.,
and Noller, H. F.
(1994)
EMBO J.
13,
3892-3901[Medline]
[Order article via Infotrieve] 28.
Hartz, D.,
McPheeters, D. S.,
Traut, R.,
and Gold, L.
(1988)
Methods Enzymol.
164,
419-425[Medline]
[Order article via Infotrieve] 29.
Anthony, D. D.,
and Merrick, W. C.
(1992)
J. Biol. Chem.
267,
1554-1562 30.
Svitkin, Y. V.,
Ovchinnikov, L. P.,
Dreyfuss, G.,
and Sonenberg, N.
(1996)
EMBO J.
15,
7147-7155[Medline]
[Order article via Infotrieve] 31.
Borovjagin, A. V.,
Pestova, T. V.,
and Shatsky, I. N.
(1994)
FEBS Lett.
351,
299-302[CrossRef][Medline]
[Order article via Infotrieve] 32.
Tzareva, N. V.,
Makhno, V. I.,
and Boni, I. V.
(1994)
FEBS Lett.
337,
189-194[CrossRef][Medline]
[Order article via Infotrieve] 33.
Sonenberg, N.,
Burley, S. K.,
and Gingras, A.-C.
(1998)
Nat. Struct. Biol.
5,
172-174[CrossRef][Medline]
[Order article via Infotrieve] 34.
Belsham, G. J.,
and Sonenberg, N.
(2000)
Trends Microbiol.
8,
330-335[CrossRef][Medline]
[Order article via Infotrieve] 35.
Kolupaeva, V. G.,
Hellen, C. U. T.,
and Shatsky, I. N.
(1996)
RNA
2,
1199-1212[Abstract] 36.
Herschlag, D.
(1995)
J. Biol. Chem.
270,
20871-20874 37.
Evdokimova, V. M.,
and Ovchinnikov, L. P.
(1999)
Int. J. Biochem. Cell Biol.
31,
139-149[CrossRef][Medline]
[Order article via Infotrieve] 38.
Haghighat, A.,
and Sonenberg, N.
(1997)
J. Biol. Chem.
272,
21677-21680
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
E. C. Anderson and A. M. L. Lever Human immunodeficiency virus type 1 gag polyprotein modulates its own translation. J. Virol., November 1, 2006; 80(21): 10478 - 10486. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Miller, K. Halbig, J. Cruz-Reyes, and L. K. Read RBP16 stimulates trypanosome RNA editing in vitro at an early step in the editing reaction RNA, July 1, 2006; 12(7): 1292 - 1303. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nashchekin, J. Zhao, N. Visa, and B. Daneholt A Novel Ded1-like RNA Helicase Interacts with the Y-box Protein ctYB-1 in Nuclear mRNP Particles and in Polysomes J. Biol. Chem., May 19, 2006; 281(20): 14263 - 14272. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Terenin, S. E. Dmitriev, D. E. Andreev, E. Royall, G. J. Belsham, L. O. Roberts, and I. N. Shatsky A Cross-Kingdom Internal Ribosome Entry Site Reveals a Simplified Mode of Internal Ribosome Entry Mol. Cell. Biol., September 1, 2005; 25(17): 7879 - 7888. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. V. Skabkina, D. N. Lyabin, M. A. Skabkin, and L. P. Ovchinnikov YB-1 Autoregulates Translation of Its Own mRNA at or prior to the Step of 40S Ribosomal Subunit Joining Mol. Cell. Biol., April 15, 2005; 25(8): 3317 - 3323. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Bader and P. K. Vogt Inhibition of Protein Synthesis by Y Box-Binding Protein 1 Blocks Oncogenic Cell Transformation Mol. Cell. Biol., March 15, 2005; 25(6): 2095 - 2106. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsumoto, K. J. Tanaka, and M. Tsujimoto An Acidic Protein, YBAP1, Mediates the Release of YB-1 from mRNA and Relieves the Translational Repression Activity of YB-1 Mol. Cell. Biol., March 1, 2005; 25(5): 1779 - 1792. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Skabkin, O. I. Kiselyova, K. G. Chernov, A. V. Sorokin, E. V. Dubrovin, I. V. Yaminsky, V. D. Vasiliev, and L. P. Ovchinnikov Structural organization of mRNA complexes with major core mRNP protein YB-1 Nucleic Acids Res., October 19, 2004; 32(18): 5621 - 5635. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fukuda, M. Ashizuka, T. Nakamura, K. Shibahara, K. Maeda, H. Izumi, K. Kohno, M. Kuwano, and T. Uchiumi Characterization of the 5'-untranslated region of YB-1 mRNA and autoregulation of translation by YB-1 protein Nucleic Acids Res., January 29, 2004; 32(2): 611 - 622. [Abstract] [Full Text] [PDF] |